Latest Breaking News On - Ida maiorino - Page 1 : comparemela.com

Meta-analysis of 23 cardiovascular outcome trials of antidiabetic agents shows that SGLT-2 inhibitors and GLP-1RAs clearly outperform DPP-4 inhibitors.

Maria ida maiorinoKatherine espositoEli lillyBruno farmaceuticiDario giuglianoBoehringer ingelheimNovo nordiskIda maiorinoDiabetes mellitus type 2Iabetes mellitus type iiType 2 diabetesDpp 4 inhibitorsDipeptidyl peptidase 4 inhibitorsHeart failureCardiovascular diseaseVd cardiovascular disease